Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Antoni Ramos Quiroga

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 9, 2021
Cognitive reserve in mental disordersSilvia Amoretti, Josep Antoni Ramos-Quiroga
Atencion Primaria|February 24, 2009
[Do we pay sufficient attention to the lack of care of hyperactivity in adults?]Josep Antoni Ramos-Quiroga, Miguel Casas Brugué
CNS Drugs|March 13, 2023
Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled TrialsGara Arteaga-Henríquez, Laura Gisbert, Josep Antoni Ramos-Quiroga
Journal of Attention Disorders|July 10, 2012
The conners' adult ADHD rating scales--short self-report and observer forms: psychometric properties of the Catalan versionJuan Antonio Amador-Campos, Juana Gómez-Benito, Josep Antoni Ramos-Quiroga
The Cochrane Database of Systematic Reviews|June 17, 2011
Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adultsXavier Castells, Josep Antoni Ramos-Quiroga, Rosa Bosch, et al.
Clinical Drug Investigation|October 15, 2025
Comparative Bioavailability of Methylphenidate Powder for Prolonged-Release Oral Suspension and Methylphenidate Prolonged-Release Chewable Tablets versus Methylphenidate Immediate-Release Tablets: Phase 1, Single-Dose, Randomised, Crossover Studies in Healthy AdultsJosep Antoni Ramos-Quiroga, Marta Forcadell Ferré, Alex Schneider-Pérez, et al.
Current Medical Research and Opinion|June 8, 2013
Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelinesJosep Antoni Ramos-Quiroga, Alonso Montoya, Alexandra Kutzelnigg, et al.
Expert Review of Neurotherapeutics|April 18, 2014
Addressing the lack of studies in attention-deficit/hyperactivity disorder in adultsJosep Antoni Ramos-Quiroga, Viviana Nasillo, Fernando Fernández-Aranda, et al.
Spanish Journal of Psychiatry and Mental Health|March 4, 2024
ADHD Rating Scale (ADHD-RS): Validation in Spanish in adult population according to the DSM-5Aldo Pereira, Vanesa Richarte, Christian Fadeuilhe, et al.
Neuroscience and Biobehavioral Reviews|July 15, 2021
Alcohol use disorders and ADHDMathias Luderer, Josep Antoni Ramos Quiroga, Stephen V Faraone, et al.
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 9, 2021
Cognitive reserve in mental disordersSilvia Amoretti, Josep Antoni Ramos-Quiroga
Atencion Primaria|February 24, 2009
[Do we pay sufficient attention to the lack of care of hyperactivity in adults?]Josep Antoni Ramos-Quiroga, Miguel Casas Brugué
CNS Drugs|March 13, 2023
Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled TrialsGara Arteaga-Henríquez, Laura Gisbert, Josep Antoni Ramos-Quiroga
Journal of Attention Disorders|July 10, 2012
The conners' adult ADHD rating scales--short self-report and observer forms: psychometric properties of the Catalan versionJuan Antonio Amador-Campos, Juana Gómez-Benito, Josep Antoni Ramos-Quiroga
The Cochrane Database of Systematic Reviews|June 17, 2011
Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adultsXavier Castells, Josep Antoni Ramos-Quiroga, Rosa Bosch, et al.
Clinical Drug Investigation|October 15, 2025
Comparative Bioavailability of Methylphenidate Powder for Prolonged-Release Oral Suspension and Methylphenidate Prolonged-Release Chewable Tablets versus Methylphenidate Immediate-Release Tablets: Phase 1, Single-Dose, Randomised, Crossover Studies in Healthy AdultsJosep Antoni Ramos-Quiroga, Marta Forcadell Ferré, Alex Schneider-Pérez, et al.
Current Medical Research and Opinion|June 8, 2013
Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelinesJosep Antoni Ramos-Quiroga, Alonso Montoya, Alexandra Kutzelnigg, et al.
Expert Review of Neurotherapeutics|April 18, 2014
Addressing the lack of studies in attention-deficit/hyperactivity disorder in adultsJosep Antoni Ramos-Quiroga, Viviana Nasillo, Fernando Fernández-Aranda, et al.
Spanish Journal of Psychiatry and Mental Health|March 4, 2024
ADHD Rating Scale (ADHD-RS): Validation in Spanish in adult population according to the DSM-5Aldo Pereira, Vanesa Richarte, Christian Fadeuilhe, et al.
Neuroscience and Biobehavioral Reviews|July 15, 2021
Alcohol use disorders and ADHDMathias Luderer, Josep Antoni Ramos Quiroga, Stephen V Faraone, et al.
Pageof 22